Characterize the function of rare CDKN2B variants identified in familial melanoma patients in support of melanoma family study
Ended Purchase Order Awarded Last action
- Contract number
- 75N91019P00661
- Awardee
-
The University Of Hong Kong UEI F7RGJJCNHMA4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,600
Award facts
- Contract value 100% obligated
- $24,600.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- China
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to The University of Hong Kong for $24,600.00 on August 23, 2019, to characterize the function of rare CDKN2B variants identified in familial melanoma patients in support of the Melanoma Family Study. Place of performance is China. The order carries firm fixed price pricing and concluded August 22, 2020.
Quick answers
Who was awarded contract 75N91019P00661?
75N91019P00661 was awarded to The University Of Hong Kong by National Cancer Institute (National Institutes of Health) on August 23, 2019.
How much is contract 75N91019P00661 worth?
The government has obligated $24,600 on 75N91019P00661.
Was contract 75N91019P00661 competed?
The extent of competition for 75N91019P00661 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award